Development of retroviral vectors for gene transfer to airway epithelia

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 5, 2000, Pages 497-506

  Wang, G ^a   Sinn, P L ^a   McCray P B , Jr ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Amphotropic; Feline immunodeficiency virus; Keratinocyte growth factor; Lentivirus; Pseudotype; Retrovirus

Indexed keywords

VIRUS VECTOR;

CYSTIC FIBROSIS; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; LENTIVIRINAE; RESPIRATORY EPITHELIUM; RETROVIRUS; REVIEW; VIRUS ENVELOPE; VIRUS RECOMBINANT; VIRUS RECOMBINATION;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIUM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; MICE; RESPIRATORY SYSTEM; RETROVIRIDAE;

EID: 0033752285     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Cystic fibrosis
2. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells
3. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer
4. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity
5. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
6. Transport function of airway epithelia and submucosal glands
7. Integrated host defense against infections
8. Gene transfer for cystic fibrosis
9. Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia
10. Regulation of human airway surface liquid
11. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium
12. Cystic fibrosis airway epithelia fall to kill bacteria because of abnormal airway surface fluid
13. The innate immune system in cystic fibrosis lung disease
14. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro
15. Keratinocyte growth factor stimulates transduction of the respiratory epithelium by retroviral vectors
16. Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry
17. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions
18. Status of gene therapy for cystic fibrosis lung disease
19. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer
20. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
21. Polarity influences the efficiency of recombinant adeno-associated virus infection in differentiated airway epithelia
22. Cell-surface receptors for retroviruses and implications for gene transfer
23. Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia in vivo
24. Antivector immunoglobulin induced by retroviral vectors
25. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells
26. High-titer packaging cells producing recombinant retroviruses resistant to human serum
27. Viral vector systems for gene therapy
28. Reconstitution of tracheal grafts with a genetically-modified epithelium
29. In vivo retroviral gene transfer into human bronchial epithelia of xenografts
30. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer
31. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
32. Proliferation indices of pulmonary epithelia during human and ovine lung development: Gene transfer targets for integrating vectors
33. Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients
34. Proliferation and differentiation in mammalian airway epithelium
35. Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic culture
36. Retrovirus-mediated gene transfer in lungs of living fetal sheep
37. Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector
38. Differentiated structure and function of cultures from human tracheal epithelium
39. Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia
40. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector
41. Development of a self-inactivating lentivirus vector
42. Lentivirus vectors using human and simian immunodeficiency virus elements
43. Lentiviral vectors for gene therapy of cystic fibrosis
44. Gene transfer vectors derived from equine infectious anemia virus
45. Efficient transduction of non-dividing human cells by feline immunodeficiency virus lentiviral vectors
46. Minimum requirements for efficient transduction of dividing and non-dividing cells by feline immunodeficiency virus vectors
47. Feline immunodeficiency virus vectors persistently transduce non-dividing airway epithelia and correct the cystic fibrosis defect
48. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo
49. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
50. Modifying the host range properties of retroviral vectors
51. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses
52. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
53. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector
54. Adenoviral/retroviral vector chimeras: A novel strategy to achieve high-efficiency stable transduction in vivo
55. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines
56. Genomic integration and gene expression by a modified adenoviral vector
57. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
58. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes
59. The role of the non-ciliated bronchiolar epithelial (Clara) cell as the progenitor cell during bronchiolar epithelial differentiation in the perinatal rabbit lung
60. Epithelial progenitor cells in the rat trachea
61. The differentiation potential of tracheal basal cells
62. 3
63. Localization of the amphotropic murine leukemia virus receptor gene to the pericentromeric region of human chromosome 8
64. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction
65. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor
66. Localization of the human gene allowing infection by gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2
67. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter
68. A family of retroviruses that utilize related phosphate transporters for cell entry
69. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?